Research & Clinical Trials
Evaluation of Belatacept as First-line Immunosuppression in De Novo Liver Transplant Recipients (IM 103-045) - Closed to Enrollment
Principal Investigator: James Spivey, MD
Study Coordinator: Faith Burnett, RN
Immune Monitoring and Assay Development in Organ Transplant Recipients - Enrolling
Principal Investigator: Allan D. Kirk, MD, PhD
Study Coordinator: Shine Thomas, CRC
The Influence of Conjugated Hyperbilirubinemia on Pulse Oximetric Accuracy in Liver Disease - Enrolling
Principal Investigator: Ram Subramanian, MD
Study Coordinator: Elizabeth Ferry, RN
The Safety of Using MRI with Gadolinium in Patients with Liver Disease - Retrospective Review
Principal Investigator: Ram Subramanian, MD
Study Coordinator: Elizabeth Ferry, RN
The Safety of Using MRI with Gadolinium in ICU Patients - Retrospective Review
Principal Investigator: Ram Subramanian, MD
Study Coordinator: Elizabeth Ferry, RN
A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type-I with Leucassin (Terlipressin) - Reverse Trial
Principal Investigator: Ram Subramanian, MD
Study Coordinator: Hernando Avila, CRC, Elizabeth Ferry, RN
